← All companies

HALO

Halozyme Therapeutics, Inc.

HALO Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$82.27

-1.03 -1.24%

Key statistics

from XBRL data in SEC filings

Market cap

$9.76B

Revenue (TTM)

$1.51B

Net income (TTM)

$349M

EPS (TTM)

$2.85

P/E ratio

28.9

Dividend yield

—

Free cash flow

$645M

Cash

$310M

Total assets

$2.67B

Gross margin

0.8%

52-week range

$58.68 – $84.44

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 2, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Shareholder vote results May 7, 2026 8-K Director or officer change Apr 30, 2026 8-K Amended charter or bylaws Apr 24, 2026 8-K Director or officer change Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Feb 17, 2026 8-K Results of operations (earnings release) Feb 17, 2026 8-K Results of operations (earnings release) Jan 28, 2026 8-K Director or officer change Dec 9, 2025 8-K Director or officer change Dec 8, 2025 8-K Director or officer change Nov 24, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Nov 12, 2025 8-K Other events Nov 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release); Director or officer change Nov 3, 2025 8-K Regulation FD disclosure Oct 14, 2025 8-K Director or officer change Oct 6, 2025 8-K Entered a material agreement Oct 3, 2025 8-K Regulation FD disclosure Oct 1, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Shareholder vote results May 2, 2025 8-K Director or officer change Mar 21, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Results of operations (earnings release) Feb 18, 2025 8-K Director or officer change Feb 13, 2025 8-K Results of operations (earnings release) Jan 8, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Shareholder vote results Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Feb 20, 2024